Article

Estimation of Healthcare-related Charges in Women with BRCA Mutations and Breast Cancer 

2021-01-07

Abstract excerpt

<title>Abstract</title> <p><bold>Background</bold>Breast cancer costs were estimated at $16.5 billion in 2010 and were higher than other cancer costs. There are limited studies on breast cancer charges and costs by BRCA mutations and receptor status. We examined overall health care and breast cancer-related charges by BRCA status (BRCAm vs. BRCAwt), receptor status (HER2+ vs. HER2-), and treatment setting (neoadj...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 244dfa70-a2b4-55cf-9ae4-256b590b5313
DOI: 10.21203/rs.3.rs-43546/v2

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Estimation of Healthcare-related Charges in Women with BRCA Mutations and Breast Cancer DOI 10.21203/rs.3.rs-43546/v2Read

Estimation of healthcare-related charges in women with BRCA mutations and breast cancer.Semantic proximity Read

Summaries for patients. The cost-effectiveness of preventive strategies for breast and ovarian cancer for women with BRCA1 or BRCA2 mutations.Semantic proximity Read

Rate of breast biopsy referrals in BRCA mutation carriers: a retrospective comparative study and matched analysisSemantic proximity Read

Factors Associated with Financial Toxicity in Patients with Breast Cancer in Japan: A Comparison of Patient and Physician PerspectivesSemantic proximity Read

Cost-Effectiveness Analysis of talazoparib Maintenance Treatment for patients with germline BRCA1/2 mutated HER2-negative advanced breast cancer in China and the USSemantic proximity Read

Outcomes of Concurrent Breast and Gynecologic Risk Reduction Surgery.Semantic proximity Read

Cost-effectiveness of Trastuzumab emtansine and Capecitabine plus lapatinib in adjuvant treatment of Human Epidermal Growth Factor Receptor 2– Positive Metastatic Breast Cancer in ChinaSemantic proximity Read

Cost-effectiveness of Universal BRCA1/2 Screening: Evidence-Based Decision Making.Semantic proximity Read

Financial toxicity in BRCA1 and BRCA2 carriers.Semantic proximity Read

Trends in Breast Cancer Mortality Among Elderly Males in the United States (1999–2020): A CDC WONDER AnalysisSemantic proximity Read

Costs of Breast Cancer Treatment Incurred by Women in VietnamSemantic proximity Read

A Cost-Effectiveness Evaluation of Germline BRCA1 and BRCA2 Testing in UK Women with Ovarian Cancer.Semantic proximity Read